Lisinopril Dosing Recommendations for Hypertension and Heart Failure
For hypertension, lisinopril should be started at 10 mg once daily and titrated up to 20-40 mg once daily as a single dose. For heart failure, start at 5 mg once daily (or 2.5 mg if hyponatremic) and titrate up to a target dose of 30-35 mg once daily. 1, 2
Dosing for Hypertension
Initial Dosing
- Standard initial dose: 10 mg once daily 1
- With diuretics: 5 mg once daily 1
- With renal impairment (CrCl ≤30 mL/min): 5 mg once daily 1
- With severe renal impairment (CrCl <10 mL/min): 2.5 mg once daily 1
Maintenance Dosing
- Usual range: 20-40 mg once daily 1
- Maximum dose: Up to 80 mg has been used but with minimal additional benefit 1
- Titration: Adjust according to blood pressure response, typically doubling the dose at 2-week intervals 2
Dosing for Heart Failure
Initial Dosing
- Standard initial dose: 5 mg once daily 1, 2
- With hyponatremia (serum sodium <130 mEq/L): 2.5 mg once daily 1
- With renal impairment (CrCl ≤30 mL/min): 2.5 mg once daily 1
Maintenance Dosing
- Target dose: 30-35 mg once daily 2
- Maximum dose: 40 mg once daily 1
- Titration: Double dose at intervals of not less than 2 weeks 2
Dosing Algorithm
Assess baseline renal function and electrolytes
- If CrCl >30 mL/min: Use standard initial doses
- If CrCl 10-30 mL/min: Use half of standard initial doses
- If CrCl <10 mL/min: Start with 2.5 mg once daily
Begin treatment
- For hypertension: Start with 10 mg once daily (or adjusted dose per renal function)
- For heart failure: Start with 5 mg once daily (or 2.5 mg if hyponatremic)
Monitor and titrate
- Check blood pressure, renal function, and electrolytes 1-2 weeks after each dose increase
- Double the dose every 2 weeks if tolerated until target dose or blood pressure goal is reached
- For heart failure, aim for the target dose of 30-35 mg daily or highest tolerated dose
Important Considerations
Evidence for Higher Doses
- The ATLAS study demonstrated that higher doses of lisinopril (32.5-35 mg daily) were more effective than lower doses (2.5-5 mg daily) in reducing hospitalizations for heart failure (24% reduction) and the combined endpoint of death or hospitalization (12% reduction) 3, 4
Monitoring
- Monitor blood chemistry (urea, creatinine, potassium) and blood pressure regularly 2
- An increase in creatinine of up to 50% above baseline is acceptable 2
- Potassium levels up to 6.0 mmol/L may be acceptable 2
Common Pitfalls and Management
Hypotension:
Cough:
Worsening renal function:
Remember that some ACE inhibitor is better than no ACE inhibitor, so aim for the target dose but settle for the highest tolerated dose if necessary 2.